Researchers at the DZNE and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination.

People with dementia are by no means evenly distributed across Germany. Researchers from the DZNE and the University Medical Center Greifswald demonstrate this with an analysis at district level. Interactive maps by the DZNE visualize the findings.

The DZNE launches the podcast "Hirn & Heinrich", in which moderator Sabine Heinrich talks to leading experts about brain diseases and the current state of research.

A genetic predisposition to late-onset Alzheimer’s disease affects how the brains of young adults cope with certain memory tasks. Researchers from the DZNE and the Ruhr-Universität Bochum report on this in the scientific journal “Current Biology”.

The DZNE is expanding its research activities to include the area of “systems medicine”. The focus is on the network of relationships between the mechanisms of brain diseases.

Study puts spotlight on a new risk factor for vascular dementia.

Researchers identify new possible entry points for SARS-CoV-2 into human bodies.

Synthetic compound could serve as prototype for a novel class of drugs to treat neurological damage.

A European research alliance headed by the DZNE tracks the onset of ataxias.

Researchers publish current coronavirus findings in "Cell"